<DOC>
	<DOCNO>NCT02676544</DOCNO>
	<brief_summary>This prospective , open label single center feasibility study demonstrate basic safety effectiveness prostate artery embolization treatment symptomatic benign prostatic Hyperplasia ( BPH ) small series patient large ( ≥90 gram ) gland .</brief_summary>
	<brief_title>Prostate Embolization Massive Benign Prostatic Hypertrophy ( BPH )</brief_title>
	<detailed_description>This prospective , open label , non-randomized , single center feasibility study evaluate technical clinical success prostatic artery embolization utilize Embosphere microspheres . At initial consultation patient screen assess severity lower urinary tract symptom ( LUTS ) relate BPH utilize international prostate symptom score ( IPSS ) . After determine eligibility , pre-procedure baseline evaluation complete . A baseline prostate ultrasound ( TRUS ) MRI require assess prostate mass , baseline prostate-specific antigen measure help exclude carcinoma also follow response therapy . Patients suspect malignancy prostate enrol without negative biopsy find . Pre- procedure urodynamic study require assess additional objective measurement exclude cause LUTS . Cystoscopy perform prior intervention help exclude bladder malignancy . If patient qualifies level symptom ( IPSS score ≥12 ) , prostate size ≥ 90 gram max urinary flow rate ( Qmax ) ≤ 12 , patient ask consider enrol study . A study investigator review propose treatment baseline/follow-up schedule . If patient agrees participate study , baseline data collect case report form appointment make prostate artery embolization interventional radiology department .</detailed_description>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>Patients select study must meet following criterion : Age ≥ 50 year Lower urinary tract symptom secondary BPH define : IPSS Symptom Index ≥ 12 Maximum Uroflow rate ( Qmax ) ≤ 12cc per sec Prostate ≥ 90 gm determine MRI transrectal ultrasound prostate ( TRUS ) Patients meet follow criterion exclude study . Age le 50 year Prostate cancer Bladder cancer Severe , lifethreatening allergy iodinate contrast Bilateral internal iliac artery occlusion Causes obstruction BPH stricture disease Neurogenic bladder cause bladder atonia Post void residual great 250 cc Any contraindication embolization , include Patients intolerant occlusion procedure Vascular anatomy blood flow precludes catheter placement embolic agent injection Presence likely onset vasospasm Presence likely onset hemorrhage Presence severe atheromatous disease Presence feeding artery small distal branch emerge Presence collateral vessel pathway potentially endanger normal territory embolization History illness surgery might confound result study , produce symptom might confuse disease process consideration , pose additional risk patient . Previous prostate surgery , balloon dilatation , stent implantation , laser prostatectomy , hyperthermia , invasive treatment prostate Confirmed suspect bladder cancer Previous rectal surgery ( hemorrhoidectomy ) history rectal disease Previous pelvic irradiation radical pelvic surgery Recent ( within 3 month ) cystolithiasis History presence urethral stricture , bladder neck contracture , potentially confound bladder pathology , ( within 5 year ) prostatitis Active urinary tract infection Concomitant medication : ( ) Use anti histaminics , anti convulsants , antispasmodic within 1 week treatment unless document evidence patient drug dose least 6 month stable void pattern ( drug dose alter discontinue entrance throughout study ) ( ii ) Use alpha blocker , anticholinergic , androgen , gonadotropinsreleasing hormonal analog within 2 month treatment ( iii ) Use 5 alpha reductase inhibitor within 6 month treatment Compromised renal function ( i.e . serum creatinine level great 1.8 mg/dl , uppertract disease )</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Prostate Artery Embolization ( PAE )</keyword>
	<keyword>Benign Prostatic Hyperplasia ( BPH )</keyword>
	<keyword>Lower Urinary Tract Symptoms ( LUTS )</keyword>
	<keyword>PAE</keyword>
	<keyword>BPH</keyword>
	<keyword>LUTS</keyword>
	<keyword>Prostate Artery Embolization</keyword>
	<keyword>Embospheres</keyword>
</DOC>